Medication info
Rabeprazole Sodium 10 mg (Rabeprazole Sodium)

Rabeprazole Sodium 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
NBK Pharmaceuticals Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
For domestic use - 28 tablets/Alu-Alu [(14 tablets/Alu-Alu x 2)]
Approval status
Active

MFDS item code 202001721 · Approved 2020.03.12 · Insurance code 054800760

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcer disease (including use in combination for eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual dose for adults is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be given orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution because hepatic function is often reduced.
Child dose
The safety of this medicine in children has not been established.

Ingredients

Manufacturer
NBK Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcer disease (including use in combination for eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for gastric ulcer, duodenal ulcer, and erosive or ulcerative gastroesophageal reflux disease. It also helps alleviate symptoms of gastroesophageal reflux disease and assists in the long-term maintenance therapy of this condition. It is effective when used in combination with antibiotics for patients with gastrointestinal ulcers infected with Helicobacter pylori. It is also applicable for Zollinger-Ellison syndrome, helping to control excessive gastric acid secretion. It is widely used in the treatment and management of major gastrointestinal diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual dose for adults is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be given orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution because hepatic function is often reduced.

Child dose

The safety of this medicine in children has not been established.

Precautions

This medication should not be used in patients with specific allergic reactions or hypersensitivity to this drug or its components. It is safer for women who are pregnant or breastfeeding not to take this medication. Patients with liver function issues or elderly individuals should use this drug carefully, and caution is needed in those with a history of drug hypersensitivity. If symptoms of hypersensitivity such as rash, urticaria, or itching occur during the use of this drug, it should be discontinued immediately, and a doctor should be consulted. It is important to regularly monitor for adverse reactions through blood tests or liver function tests. This drug may cause various side effects such as gastrointestinal symptoms, cardiac-related anomalies, and neurological symptoms; if any symptoms occur, inform medical personnel. Long-term use may increase the risk of osteoporosis and fractures, so management of bone health is necessary if used for an extended period. This medication may interact with other drugs; if other medications are being taken, it must be reported to the medical staff. Particular caution is needed when used in conjunction with certain antibiotics, antivirals, and anticoagulants, and it should not be combined with some medications. Caution is advised when driving or operating machinery, as drowsiness may occur during the use of this drug. While taking this medication, do not chew or crush the tablet; it should be swallowed whole. It should be kept out of reach of children, and transferring to another container is not recommended. In case of overdose, there is no specific antidote, so treatment and supportive therapy based on symptoms should be undertaken.

Side effects

Rash, hives, itching, reduced erythrocytes, reduced leukocytes, increased leukocytes, increased eosinophils, increased neutrophils, reduced lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal ECG, migraine, syncope, angina, blockade, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, indigestion, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, perceptual dulness, decreased grip strength, language confusion, staggering, disturbance of orientation, hypersomnolence, cough, pharyngitis, rhinitis, difficulty breathing, asthma, nosebleed, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, decreased respiration, interstitial pneumonia, myalgia, lumbago, arthritis, leg cramps, bone pain, arthropathy, bursitis, excessive muscle tension, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucocutaneous syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urination difficulty, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, lethargy, weight gain, visual disturbances, decreased appetite, neck stiffness, photosensitive reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The optimal storage temperature is between 1 and 30 degrees Celsius, to maintain the efficacy and safety of the drug for a long time.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

For domestic use - 28 tablets/Alu-Alu [(14 tablets/Alu-Alu x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.